Private Label White Willow Feverfew Standardized, 60 Capsules

Private Label White Willow Feverfew Standardized, 60 Capsules, for Joint and Mobility Ranges

Private Label White Willow Feverfew Standardized is a 60-count capsule blend of white willow bark (Salix alba), standardized to 15% salicin, with feverfew (Tanacetum parthenium), manufactured to order in BioB MFG's GMP-certified facility in Hauppauge, New York, with flexible minimums and private label support from concept to finished goods.

White willow bark and feverfew are a traditional botanical pairing with long-established recognition in Western and European herbal practice, and that recognition is the commercial asset. A brand listing this blend does not have to explain two unfamiliar ingredients before it can sell anything; both names are already known to the herbal shopper, and the pairing reads as deliberate rather than assembled. The standardization is what turns a familiar pairing into a specification a buyer can hold a manufacturer to. Brands merchandising into the joint and everyday mobility shelf, traditional-blend herbal ranges, practitioner-channel lines and DTC subscription assortments are the natural audience for a 60-count bottle at this specification level.

Specifications

Product type: Standardized botanical blend capsule, private label

Botanical / actives: White willow bark (Salix alba), standardized to 15% salicin, with feverfew (Tanacetum parthenium)

Base: Capsule

Size: 60 capsules per bottle

Manufacturing: Made in the USA from globally sourced ingredients

Facility: GMP-certified (Hauppauge, NY)

Certifications: NSF, USDA Organic, Kosher, and Halal available

Minimum order: 300,000 capsules or tablets total; request a quote for exact MOQ and price breaks

Customization: Custom packaging and full formulation support

Private label: Yes, concept to finished goods

What Is a Standardized Botanical Capsule?

A standardized botanical capsule is one manufactured to a stated marker level rather than to weight of raw herb alone — here, white willow bark standardized to 15% salicin. Standardization is a manufacturing control, and its value to a brand is repeatability. Botanical raw material varies by harvest, growing region and season, so two lots of unstandardized bark can differ meaningfully in composition while both being honestly labelled as white willow bark. Standardizing to a marker gives the manufacturer a target to formulate against and gives the brand a specification that stays constant from the first production run to the fifth. That matters commercially in two concrete ways: a retailer's quality team can evaluate the product against a number rather than a description, and a reorder in eighteen months produces a bottle matching the one the customer bought today. A generic unstandardized blend offers neither guarantee. The 15% salicin figure is stated here strictly as a production specification and a consistency argument; it is not offered as a statement about what the product does.

Market Demand

The shelf this blend is merchandised into is large and growing steadily. Grand View Research sizes the global bone and joint health supplements market at USD 14.2 billion in 2024 and USD 16.2 billion in 2026, growing to USD 27.2 billion by 2033 at a 7.6% CAGR. The herbal category feeding it is growing faster still: Grand View Research puts herbal supplements at USD 42.3 billion in 2024, rising to USD 90.2 billion by 2033 at an 8.9% CAGR, and botanical supplements at USD 38.2 billion in 2024, growing to USD 67.0 billion by 2030 at a 9.9% CAGR. For a brand deciding whether to build production or buy it, the relevant number is the outsourcing curve: Grand View Research values supplement contract manufacturing at USD 22.6 billion in 2025, growing to USD 58.9 billion by 2033 at a 12.8% CAGR from 2026 to 2033 — expansion faster than the supplement categories it supplies, which tells you where brands are choosing to put their capital.

Private Label Opportunity

A standardized traditional blend is one of the more defensible private label positions available, because it is difficult to undercut without visibly cutting the specification. Anyone can list a white willow and feverfew capsule; listing one standardized to 15% salicin, made in a GMP-certified US facility, with certification options and batch documentation, is a different proposition and a different price conversation. The product can hold a mid-to-premium price point on the joint and mobility shelf without relying on packaging alone to justify it. The 60-count bottle is a standard retail and subscription configuration that sits naturally beside 30- and 90-count SKUs in a range. Brands specify bottle, closure, carton and label artwork and take delivery of finished goods, not bulk. Full formulation support means the blend can be listed as supplied or used as the base of a proprietary formula, without changing manufacturers to do it.

Competitive Landscape

The competing formats on this shelf are single-botanical white willow capsules, single-botanical feverfew capsules, unstandardized two-herb blends, liquid tinctures of either botanical, and large multi-ingredient joint formulas carrying eight or ten line items. Single-botanical SKUs are simpler to document but give up the traditional pairing that makes this listing recognisable. Unstandardized blends compete directly on shelf and lose on specification: without a marker level, a brand has nothing to promise a retailer beyond the ingredient names. Tinctures serve a liquid-preferring shopper and a different merchandising set. Sprawling multi-ingredient formulas dilute both botanicals into a proprietary blend where neither is meaningfully specified. This product's distinct position is the combination the alternatives miss: a recognisable traditional pairing, a stated standardization on the primary botanical, part and species named for both, and one US manufacturer accountable from raw material to finished bottle.

Why Brands Choose This Formula

Brands choose this formula because it gives their quality, marketing and sourcing teams the same answer. The botanicals are specified by part and species — white willow bark (Salix alba) and feverfew (Tanacetum parthenium) — so the label can be precise rather than approximate. The 15% salicin standardization gives the specification a number, which makes reorders comparable and retailer conversations shorter. Manufacturing is in the USA from globally sourced ingredients in a GMP-certified facility in Hauppauge, New York, a verifiable and auditable address. NSF, USDA Organic, Kosher and Halal certification are available so the finished goods can match a specific channel's requirements. Capsule minimums are 300,000 capsules or tablets total, and formulation support comes alongside manufacturing, so a brand can launch on the blend as specified and evolve it later with the same supplier and documentation trail.

Common Buyer Questions

What is a private label white willow and feverfew capsule?

It is a finished capsule product manufactured by BioB MFG and sold under your brand name rather than ours. We handle the botanical material, standardization, encapsulation, bottling, labelling and finished-goods packaging for a 60-count blend of white willow bark and feverfew; you own the brand, artwork, pricing and customer relationship.

What does standardized to 15% salicin mean?

It means the white willow bark used in this formula is produced to a specification of 15% salicin content, stated as a manufacturing target rather than as a description of any effect. Standardization exists to make production repeatable: it gives the manufacturer a consistent formulation target across varying harvests and the brand a specification that stays the same across production runs, which is what makes a reorder match the original.

What species and plant parts are used?

White willow bark from Salix alba and feverfew from Tanacetum parthenium. The bark is the part used for white willow, specified deliberately because bark and other plant parts are not interchangeable and a label naming only the common name leaves that ambiguous. Feverfew is identified at the species level for the same reason. Beyond the stated 15% salicin standardization, this item carries no additional compound or marker claims.

What is your minimum order quantity (MOQ)?

Minimum order quantities vary by format. Liquid products under 8 oz start at 5,000 units; 8 oz and larger liquids start at 2,500 units. Capsule and tablet products have a minimum of 300,000 capsules or tablets total. Request a quote and we'll confirm exact MOQ and price breaks for your project.

Can the packaging and label be customized?

Yes. Bottle, closure, carton, count configuration and label artwork are specified by the brand, and custom packaging is supported as standard. Full formulation support is included, so a brand can list the blend exactly as supplied or build it into a broader proprietary formula. Send finished artwork and we will produce to it, or work with our team if the design and packaging specification are still being settled.

Is the product manufactured to certified quality standards?

Yes. Production runs in BioB MFG's GMP-certified facility in Hauppauge, New York, and the product is made in the USA from globally sourced ingredients. NSF, USDA Organic, Kosher and Halal certifications are available, and batch documentation accompanies the production run. Confirm the certification set you require at the quote stage.

What wellness category does this product fit?

Retailers merchandise white willow and feverfew blends into the joint and everyday mobility set, alongside traditional herbal and single-botanical ranges — a description of where the product is stocked, not of what it does. BioB MFG supplies the manufacturing, the standardization specification and the batch documentation; the claims a brand makes on its own label are the brand's decision and should be reviewed against the rules for its market and channel.

Can BioB MFG manufacture this as a private label supplement?

Yes. This is a made-to-order private label product handled from concept to finished goods: sourcing, standardized botanical material, encapsulation, bottling, labelling, certification where required, batch documentation, and packaged product delivered to your warehouse. Capsule minimums are 300,000 capsules or tablets total. Request a quote with your count, certification set and volume, and we will confirm exact MOQ and price breaks.

Updated September 2026